| Literature DB >> 29999240 |
Tao Peng1, Wencui Wan2, Jingtao Wang1, Yu Liu1, Zhenqiang Fu1, Xingrong Ma1, Junmin Li1, Guifang Sun1, Yangfei Ji1, Jingjing Lu1, Hong Lu1, Yufeng Liu3.
Abstract
Endothelial dysfunction is fundamental to ischemic stroke and brain injury. The humanin analogue S14G-humanin (HNG) has been shown to be a cytoprotective derivative. In this study, we investigated the neuroprotective effects of HNG in vivo and in vitro. In a murine middle cerebral artery occlusion (MCAO) stroke model, HNG ameliorates cerebral infarction and suppresses the production of TNF-α, IL-1β, IL-6 and MCP-1 cytokines. HNG inhibits the expression of vascular adhesion molecules such as VCAM-1 and ICAM-1 in the cortex tissue. In mouse brain endothelial cells bEnd.3, HNG protects cell survival under oxygen deprivation (OGD) conditions. HNG suppresses ROS production as well as that of the same panel of cytokines and vascular adhesion molecules induced by OGD. HNG also reduces the numbers of THP-1 cells attached to bEnd.3 by OGD. Mechanistically, we show that HNG exerts its effect via inhibition of the NF- κB pathway factor IKKα, activation of IκBα and accumulation of p65 in the nucleus. Our data conclude that S14G-humanin serves as a neuroprotective factor, especially in brain vascular disorders.Entities:
Keywords: MCAO model; NF-κB; S14G-humanin (HNG); brain endothelial cells; neurovascular protection
Mesh:
Substances:
Year: 2018 PMID: 29999240 DOI: 10.1002/iub.1869
Source DB: PubMed Journal: IUBMB Life ISSN: 1521-6543 Impact factor: 3.885